2011
DOI: 10.1038/bjc.2011.124
|View full text |Cite
|
Sign up to set email alerts
|

Allelic imbalance of the TGFβR1 is not a major contributor to the genetic predisposition to colorectal cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
6
0

Year Published

2011
2011
2016
2016

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(6 citation statements)
references
References 6 publications
0
6
0
Order By: Relevance
“…More recently, contrary results were reported, in that the ASE of TGFBR1 was observed as a rare event and no increased susceptibility to CRC could be detected [9][14].…”
Section: Introductionmentioning
confidence: 69%
See 3 more Smart Citations
“…More recently, contrary results were reported, in that the ASE of TGFBR1 was observed as a rare event and no increased susceptibility to CRC could be detected [9][14].…”
Section: Introductionmentioning
confidence: 69%
“…Recently, a phenomenon called “allele-specific expression” (ASE) was described; ASE occurs in the germline at the TGFBR1 gene in 10%–20% of CRC patients and generates an increased risk of CRC (odds ratio [OR]: 8.7; 95% confidence interval [CI]: 2.6–29.1), although the underlying genetic cause of this transcriptional variation remains unknown [8] . More recently, contrary results were reported, in that the ASE of TGFBR1 was observed as a rare event and no increased susceptibility to CRC could be detected [9] [14] .…”
Section: Introductionmentioning
confidence: 69%
See 2 more Smart Citations
“…We appreciate the data and comments provided by Abadie et al (2011) regarding our recent report ‘No association between germline allele-specific expression of TGFBR1 and colorectal cancer risk in Caucasian and Ashkenazi populations' ( Segui et al , 2011 ). They provide new compelling data corroborating our latest findings, which indicate that allele-specific expression (ASE) of TGFBR1 does not confer an increased risk of colorectal cancer (CRC).…”
mentioning
confidence: 99%